CLL-246 Venetoclax-Obinutuzumab for Previously Untreated Chronic Lymphocytic Leukemia: 5-Year Results of the Randomized CLL14 Study

Autor: Al-Sawaf, Othman ^{1, 2, 3}, Zhang, Can ¹, Robrecht, Sandra ¹, Kotak, Alex ⁴, Chang, Naomi ⁴, Fink, Anna ¹, Tausch, Eugen ⁵, Schneider, Christof ⁵, Ritgen, Matthias ⁶, Kreuzer, Karl ¹, Chyla, Brenda ⁷, Eichhorst, Barbara ¹, Jiang, Yanwen ⁸, Stilgenbauer, Stephan ⁵, Hallek, Michael ¹, Fischer, Kirsten ¹

Publikováno v: In Clinical Lymphoma, Myeloma and Leukemia October 2022 22 Supplement 2:S274-S275

Phase 1/2 Study of Lumasiran for Treatment of Primary Hyperoxaluria Type 1

Autor: Frishberg, Yaacov, Deschênes, Georges, Groothoff, Jaap W., Hulton, Sally-Anne, Magen, Daniella, Harambat, Jérôme, van’t Hoff, William G., Lorch, Ulrike, Milliner, Dawn S., Lieske, John C., Haslett, Patrick, Garg, Pushkal P., Vaishnaw, Akshay K., Talamudupula, Sandeep, Lu, Jiandong, Habtemariam, Bahru A., Erbe, David V., McGregor, Tracy L., Cochat, Pierre, Bandara, Asela, Bowen, Jonathan, Chong, Wei Li, Coates, Simon, De Barr, Patrick, De Beer, Janine, Gayed, Juleen, Hill, Timothy, Kotak, Alex, Ono, Junko, Taubel, Jorg, Thayalan, Meera, Wong, Robynne, Coch, Christoph, Coenen, Martin, Feldkotter, Markus, Heiland, Nils Henning, Hohenadel, Maximilian, Hoppe, Bernd, Kyrieleis, Henriette, Schalk, Gesa, Cooper, Lucy, Gupta, Asheeta, Milford, David, Muorah, Mordi, Bacchetta, Justine, Bernoux, Delphine, Bertholet-Thomas, Aurelia, Cheyssac, Elodie, Portefaix, Aurelie, Ranchin, Bruno, Sellier-Leclerc, Anne-Laure, Llanas, Brigitte, Baudouin, Veronique, Couderc, Anne, Hogan, Julien, Kaguelidou, Florentia, Kwon, Theresa, Maisin, Anne, Sas, David, Becker-Cohen, Rachel, Ben-Shalom, Efrat, Rinat, Choni, Behr, Shimrit Tzvi, Bockenhauer, Detlef, Mansour, Bshara, Pollack, Shirley, Garrelfs, Sander, Oosterveld, Michiel, Moochhala, Shabbir, Walsh, Stephen, Kamesh, Lavanya, Lipkin, Graham

Publikováno v: Clinical Journal of The American Society of Nephrology; July 2021, Vol. 16 Issue: 7 p1025-1036, 12p

Author Correction: Transcriptomic profiles and 5-year results from the randomized CLL14 study of venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab in chronic lymphocytic leukemia.

Autor: Al-Sawaf, Othman, Zhang, Can, Jin, Hyun Yong, Robrecht, Sandra, Choi, Yoonha, Balasubramanian, Sandhya, Kotak, Alex, Chang, Yi Meng, Fink, Anna Maria, Tausch, Eugen, Schneider, Christof, Ritgen, Matthias, Kreuzer, Karl-Anton, Chyla, Brenda, Paulson, Joseph N., Pallasch, Christian P., Frenzel, Lukas P., Peifer, Martin, Eichhorst, Barbara, Stilgenbauer, Stephan

Publikováno v: Nature Communications; 10/23/2023, Vol. 14 Issue 1, p1-1, 1p

Presentation of metastatic renal cell carcinoma as a lip lesion.

Autor: Kotak A; Department of Oral and Maxillofacial Surgery, Musgrove Park Hospital, Somerset, UK akotak09@hotmail.co.uk., Merrick G; Department of Oral and Maxillofacial Surgery, Musgrove Park Hospital, Somerset, UK.

Publikováno v: Journal of surgical case reports [J Surg Case Rep] 2014 Sep 09; Vol. 2014 (9). Date of Electronic Publication: 2014 Sep 09.